Mind Medicine (MNMD) Misses Q1 EPS by 1c

Mind Medicine (NASDAQ: MNMD) reported Q1 EPS of ($0.35), $0.01 worse than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Mind Medicine (MNMD) click here.

You May Also Be Interested In

• Cantor Fitzgerald Downgrades Monopar Therapeutics (MNPR) to Neutral
• Axis Capital Limited Downgrades National Aluminium (NACL:IN) to Sell (4)
• Spruce Biosciences (SPRB) PT Lowered to $144 at Citizens on Higher OpEx, Net Loss